Gilead Sciences' Q4 2024 results, driven by HIV drug demand and Trodelvy growth, make it a compelling choice for long-term ...

David Furnish’s leadership at EJAF proves brands can do more than raise awareness —they can dismantle stigma and drive ...

Salesforce's outlook fell short of analysts’ expectations, sending shares lower in extended trading Wednesday.

Dr Hamied, as the scientist-entrepreneur is better known, is not particularly concerned about the impact of tariffs on ...

It was a busy week for the biotech sector. While the fourth-quarter earnings season is nearing the end, other pipeline and ...

Derived prices are not provided by exchanges. They are derived by market makers in CFD OTC market and hence prices may not be accurate and may differ from the actual market price, meaning prices ...

The FDA has accepted the biologics licensing application (BLA) resubmission for odronextamab, a potential treatment for ...

David Winand, financial advisor for Edward Jones, was the speaker at the Morrow Chamber of Commerce “Lunch and Learn” meeting ...

Concerned Citizens of Morrow County held a community meeting Feb. 19 regarding the Crossroads Solar Project being planned ...